Simplify Propel Opportuni... (SURI)
AMEX: SURI
· Real-Time Price · USD
15.81
0.12 (0.77%)
At close: Sep 05, 2025, 3:59 PM
15.81
0.00%
After-hours: Sep 05, 2025, 05:05 PM EDT
0.77% (1D)
| Bid | 15.5 |
| Market Cap | 68.04M |
| AUM | 68.93M |
| NAV | 15.7 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 4.3M |
| Inception Date | Feb 7, 2023 |
| Ask | 17.47 |
| Volume | 90 |
| Open | 15.81 |
| Previous Close | 15.69 |
| Day's Range | 15.81 - 15.81 |
| 52-Week Range | 12.71 - 27.52 |
| Holdings | 19 |
| Expense Ratio | 2.79% |
About SURI
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation. The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.
Asset Class Equity
Ticker Symbol SURI
Inception Date Feb 7, 2023
Provider Simplify
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 80.66% of assets
| Name | Symbol | Weight |
|---|---|---|
| Plains Gp Holdings, ... | PAGP | 34.17% |
| Akero Therapeutics, ... | AKRO | 9.49% |
| Milestone Pharmaceut... | MIST | 7.43% |
| Phathom Pharmaceutic... | PHAT | 5.79% |
| Abeona Therapeutics ... | ABEO | 5.61% |
| Achieve Life Science... | ACHV | 4.89% |
| Delcath Systems, Inc... | DCTH | 4.43% |
| Applied Therapeutics... | APLT | 3.10% |
| Tscan Therapeutics, ... | TCRX | 2.92% |
| Celldex Therapeutics... | CLDX | 2.83% |
Dividends Dividend Yield 17.55%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 25, 2025 | $0.6800 | Jun 30, 2025 |
| Mar 26, 2025 | $0.6800 | Mar 31, 2025 |
| Dec 23, 2024 | $0.6800 | Dec 31, 2024 |
| Sep 25, 2024 | $0.6800 | Sep 30, 2024 |
| Jun 25, 2024 | $1.2500 | Jun 28, 2024 |
